|
Sun Pharma faces potential impact from the US 100% tariff on patented drugs, which could reduce FY2627 earnings by 810%. Generic drugs remain exempt. The companys innovative portfolio, strong cash position, and mitigation options support steady revenue growth, maintaining HSBCs Buy rating with Rs 1,850 target.
Category:
News and Media
Spirit maker Alcobrew Distilleries India Ltd has filed draft papers with capital markets regulator Sebi to seek its approval to raise funds through an initial public offering (IPO).
Category:
News and Media
The combined market valuation of the top-10 most valued firms eroded by Rs 2,99,661.36 crore last week, in line with a bearish trend in equities, with IT bellwether Tata Consultancy Services taking the biggest hit.
Category:
News and Media
All news |
||||||||||||||||||
|